Market Sentiment for AMGN

Live Market Sentiment

Neutral (0.0314)

(Latest daily score)

Predicted Return

10.42%

7-day sentiment average

Advisory Opinion

Buy

Derived from sentiment trend

News Items (period)

2,206

The table below gives each of the most recent headlines of the stock and the negative, neutral, positive aggregated sentiment score.

Date	Headline	Source	Sentiment
2026-04-03	This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.	24/7 Wall St.	Negative (-0.2539)
2026-04-03	How Tavneos Safety Risks and New Oncology Pact Could Rebalance Amgen’s (AMGN) Risk‑Reward Profile	Simply Wall St.	Positive (0.3168)
2026-04-02	2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory	Motley Fool	Strong Negative (-0.6307)
2026-04-02	Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors	Zacks	Negative (-0.2366)
2026-04-02	Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now?	Insider Monkey	Positive (0.1727)
2026-04-01	Why 2026 Is Biotech’s Comeback Year	Barrons.com	Neutral (0.0756)
2026-04-01	Eli Lilly Stock Jumps as Weight-Loss Pill Enters the Market. What It Means for Novo Nordisk.	Barrons.com	Neutral (0.0517)
2026-04-01	Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy	Business Wire	Strong Positive (0.8839)
2026-03-31	TEVA's Prolia Biosimilar Gets FDA Nod, Xolair Filing Accepted	Zacks	Strong Positive (0.6774)
2026-03-31	FDA Says Amgen’s Tavneos Linked to Liver Injuries, Deaths	The Wall Street Journal	Strong Negative (-0.6803)